2022
DOI: 10.1177/08853282221125309
|View full text |Cite
|
Sign up to set email alerts
|

In vitro and in vivo assessment of a novel ultra-flexible ventriculoamniotic shunt for treating fetal hydrocephalus

Abstract: Fetal aqueductal stenosis (AS) is one of the most common causes of congenital hydrocephalus, which increases intracranial pressure due to partial or complete obstruction of cerebrospinal fluid (CSF) flow within the ventricular system. Approximately 2–4 infants per 10,000 births develop AS, which leads to progressive hydrocephalus, which enlarges the head often necessitating delivery by cesarean section. Most babies born with AS are severely neurologically impaired and experience a lifetime of disability. There… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 44 publications
0
1
0
Order By: Relevance
“…In-utero intervention for fetal AS by a purposedesigned ventriculoamniotic shunt and endoscopic third ventriculostomy (ETV) is being investigated in a large animal model. If a benefit is documented in the animal model, demonstrating the ability to make an accurate prenatal diagnosis of fetal AS is required before translation to humans [9,[15][16][17][18].…”
Section: Discussionmentioning
confidence: 99%
“…In-utero intervention for fetal AS by a purposedesigned ventriculoamniotic shunt and endoscopic third ventriculostomy (ETV) is being investigated in a large animal model. If a benefit is documented in the animal model, demonstrating the ability to make an accurate prenatal diagnosis of fetal AS is required before translation to humans [9,[15][16][17][18].…”
Section: Discussionmentioning
confidence: 99%